biospecimen__admin__batch_number	304.64.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	ACC
biospecimen__admin__file_uuid	78C6C675-C167-42A9-9DF7-D2C7ED71934C
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-OR-A5JY-01A-31R
biospecimen__bio__bcr_portion_barcode	TCGA-OR-A5JY-01A-31
biospecimen__bio__bcr_sample_barcode	TCGA-OR-A5JY-01A
biospecimen__bio__biospecimen_barcode_bottom	0145632260
biospecimen__bio__day_of_creation	04
biospecimen__bio__day_of_shipment	08
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-OR-A5JY.8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6.pdf
biospecimen__bio__plate_column	4
biospecimen__bio__plate_id	A29S
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	3
biospecimen__bio__quantity	2.08
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-OR-A5JY
biospecimen__shared__patient_id	A5JY
clinical__acc_shared__excess_adrenal_hormone_diagnosis_method_type	Both Clinical and Biochemical Assessments
clinical__acc_shared__excess_adrenal_hormone_history_type	Cortisol
clinical__acc_shared__invasion_of_tumor_capsule	Invasion of Tumor Capsule Present
clinical__acc_shared__metastatic_neoplasm_confirmed_diagnosis_method_name	Other, specify
clinical__acc_shared__metastatic_neoplasm_confirmed_diagnosis_method_text	surgical resection
clinical__acc_shared__metastatic_neoplasm_initial_diagnosis_anatomic_site	Liver
clinical__acc_shared__mitoses_count	60
clinical__acc_shared__mitotane_therapy	YES
clinical__acc_shared__mitotane_therapy_adjuvant_setting	NO
clinical__acc_shared__mitotane_therapy_for_macroscopic_residual_disease	YES
clinical__acc_shared__mitotic_rate	Mitotic Rate > 5/50 HPF Present
clinical__acc_shared__necrosis	Necrosis Present
clinical__acc_shared__therapeutic_mitotane_lvl_macroscopic_residual	NO
clinical__acc_shared__weiss_venous_invasion	Venous Invasion Present
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	D7979481-990F-4229-81FC-FD1BC557E8CD
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__clin_shared__age_at_initial_pathologic_diagnosis	68
clinical__clin_shared__ct_scan	YES
clinical__clin_shared__ct_scan_findings	Vena Cava Involvement/thrombus
clinical__clin_shared__day_of_form_completion	10
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__laterality	Right
clinical__clin_shared__lymph_node_examined_count	2
clinical__clin_shared__month_of_form_completion	9
clinical__clin_shared__number_of_lymphnodes_positive_by_he	1
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_surgical_procedure_assessment_thyroid_gland_carcinoma_status	Persistent distant metastases
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__primary_lymph_node_presentation_assessment	YES
clinical__clin_shared__primary_therapy_outcome_success	Progressive Disease
clinical__clin_shared__radiation_therapy	YES
clinical__clin_shared__residual_tumor	R2
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Adrenal
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	75
clinical__nte__new_neoplasm_confirmed_diagnosis_method_name	Imaging
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Lung
clinical__nte__new_neoplasm_event_type	Distant Metastasis
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rad__anatomic_treatment_site	Primary Tumor Field
clinical__rad__bcr_radiation_barcode	TCGA-OR-A5JY-R48311
clinical__rad__bcr_radiation_uuid	F1C55ED1-50FD-423A-94E3-1C9D22E54007
clinical__rad__days_to_radiation_therapy_end	93
clinical__rad__days_to_radiation_therapy_start	78
clinical__rad__radiation_dosage	30
clinical__rad__radiation_treatment_ongoing	NO
clinical__rad__radiation_type	External
clinical__rad__units	Gy
clinical__rx__bcr_drug_barcode	TCGA-OR-A5JY-D48310
clinical__rx__bcr_drug_uuid	1125569B-151B-4740-A864-9F8BFC63E2B4
clinical__rx__days_to_drug_therapy_end	93
clinical__rx__days_to_drug_therapy_start	78
clinical__rx__drug_name	xeloda
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Adrenocortical carcinoma- Usual Type
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__other_dx	No
clinical__shared_stage__clinical_m	M1
clinical__shared_stage__pathologic_n	N1
clinical__shared_stage__pathologic_t	T4
gcm_curated__age	25190
gcm_curated__alt_biosample_source_id	TCGA-OR-A5JY-01A
gcm_curated__alt_donor_source_id	TCGA-OR-A5JY
gcm_curated__alt_item_source_id	TCGA-OR-A5JY-01A-31R-A29S-07
gcm_curated__assembly	GRCh38
gcm_curated__biological_replicate_count	1
gcm_curated__biological_replicate_number	1
gcm_curated__biosample_source_id	2c8d4883-588e-441e-b20c-6208346d1f23
gcm_curated__biosample_type	tissue
gcm_curated__case_source_id	344f7ea4-2bd4-4f2d-89f2-9fc7f572a3d6
gcm_curated__checksum	1493c86e1547156c87574ada19a4f32e
gcm_curated__data_type	Gene Expression Quantification
gcm_curated__dataset_name	GRCh38_TCGA_gene_expression_2019_10
gcm_curated__date	2019-09-12T10:50:49.000000+02:00
gcm_curated__disease	Adrenocortical Carcinoma
gcm_curated__donor_source_id	344f7ea4-2bd4-4f2d-89f2-9fc7f572a3d6
gcm_curated__ethnicity	white
gcm_curated__external_reference	https://portal.gdc.cancer.gov/cases/344f7ea4-2bd4-4f2d-89f2-9fc7f572a3d6
gcm_curated__feature	gene expression
gcm_curated__file_format	BED
gcm_curated__file_name	1fe73f5c-591d-4c55-ae0e-a67afb64f872-geq.bed
gcm_curated__gender	female
gcm_curated__is_annotation	false
gcm_curated__is_healthy	false
gcm_curated__item_source_id	1fe73f5c-591d-4c55-ae0e-a67afb64f872-geq
gcm_curated__local_url	http://www.gmql.eu/gmql-rest/datasets/public.GRCh38_TCGA_gene_expression_2019_10/1fe73f5c-591d-4c55-ae0e-a67afb64f872-geq/region
gcm_curated__pipeline	HTSeq - Counts, HTSeq - FPKM, HTSeq - FPKM-UQ
gcm_curated__project_name	TCGA-ACC
gcm_curated__replicate_source_id	2c8d4883-588e-441e-b20c-6208346d1f23
gcm_curated__size	5111421
gcm_curated__source	TCGA
gcm_curated__source_page	https://portal.gdc.cancer.gov/files/b73af8c1-946a-4542-811b-4bf7abdc06a4,https://portal.gdc.cancer.gov/files/45f3cc69-fca0-49aa-bd79-8eb94920c4ed,https://portal.gdc.cancer.gov/files/9b3520b4-dc1d-4478-8453-f53f7b4a0d95
gcm_curated__source_site	University of Michigan
gcm_curated__source_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/1fe73f5c-591d-4c55-ae0e-a67afb64f872-geq.bed
gcm_curated__species	Homo sapiens
gcm_curated__technical_replicate_count	1
gcm_curated__technical_replicate_number	1_1
gcm_curated__technique	RNA-Seq
gcm_curated__tissue	Adrenal gland
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	1fe73f5c-591d-4c55-ae0e-a67afb64f872
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-OR-A5JY-01A-31R-A29S-07
gdc__aliquots__updated_datetime	2018-11-27T10:01:29.779572-06:00
gdc__analysis__analysis_id	78713aa0-4e10-4671-80e2-6c9bdda69a0b,884ac3fa-4fb2-4f04-b22c-299d15e0daf9,6f0ffb25-fcc0-49ed-838b-d341e00e831e
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM-UQ,HTSeq - FPKM,HTSeq - Counts
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.82
gdc__analytes__analyte_id	e6c63a9a-86ab-4550-bd93-93daa2d28d2c
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__concentration	0.16
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	344f7ea4-2bd4-4f2d-89f2-9fc7f572a3d6
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:10:59.295169-05:00,2016-05-29T10:10:59.482434-05:00,2016-05-29T10:10:59.021076-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__age_at_index	68
gdc__demographic__days_to_birth	-25190
gdc__demographic__days_to_death	552
gdc__demographic__demographic_id	abdd7dfe-d255-5505-afe1-5cdddd8db602
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__vital_status	Dead
gdc__demographic__year_of_birth	1943
gdc__demographic__year_of_death	2012
gdc__diagnoses__age_at_diagnosis	25190
gdc__diagnoses__ajcc_clinical_m	M1
gdc__diagnoses__ajcc_pathologic_n	N1
gdc__diagnoses__ajcc_pathologic_t	T4
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_diagnosis	0
gdc__diagnoses__diagnosis_id	124c3b73-c165-5a4e-990d-be9f8b053a2d
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8370/3
gdc__diagnoses__primary_diagnosis	Adrenal cortical carcinoma
gdc__diagnoses__prior_malignancy	no
gdc__diagnoses__prior_treatment	No
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Cortex of adrenal gland
gdc__diagnoses__tissue_or_organ_of_origin	Cortex of adrenal gland
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iv
gdc__diagnoses__year_of_diagnosis	2011
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__alcohol_history	Not Reported
gdc__exposures__exposure_id	4ec8fff2-28f0-502f-b4d5-41783b94b411
gdc__file_id	b73af8c1-946a-4542-811b-4bf7abdc06a4,45f3cc69-fca0-49aa-bd79-8eb94920c4ed,9b3520b4-dc1d-4478-8453-f53f7b4a0d95
gdc__file_name	e85942cf-02d4-45f4-b06b-d01e53711241.FPKM-UQ.txt.gz,e85942cf-02d4-45f4-b06b-d01e53711241.FPKM.txt.gz,e85942cf-02d4-45f4-b06b-d01e53711241.htseq.counts.gz
gdc__file_size	512012,509605,251302
gdc__input_files__access	controlled
gdc__input_files__data_category	Sequencing Reads
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__file_id	7b0c2b6c-4780-47b9-81b8-30fa00a7b6ac
gdc__input_files__file_name	04f061d3-4aff-4f57-a8a3-4d2e72380176_gdc_realn_rehead.bam
gdc__input_files__file_size	8787311168
gdc__input_files__md5sum	f1874dc67f1d7a651ca668bce20eb21d
gdc__input_files__platform	Illumina
gdc__md5sum	9221fa18ee2018011a3d78c075092d6f,c5662023f14a6366aa031cfb75724e0c,0143399ae6adfdb3be51694c463273a0
gdc__portions__is_ffpe	false
gdc__portions__portion_id	69341428-0c65-400f-a02f-6db6f93280fb
gdc__portions__portion_number	31
gdc__portions__weight	30.0
gdc__primary_site	Adrenal gland
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Adrenocortical Carcinoma
gdc__project__project_id	TCGA-ACC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	414
gdc__samples__initial_weight	190.0
gdc__samples__is_ffpe	false
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	8D4E0E4D-9C84-4F29-AFD9-91EEEC158ED6
gdc__samples__sample_id	2c8d4883-588e-441e-b20c-6208346d1f23
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__samples__tissue_type	Not Reported
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	20.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	379e24e0-0700-49c2-8b81-b5a1713bdf67
gdc__submitter_id	e85942cf-02d4-45f4-b06b-d01e53711241_uqfpkm,e85942cf-02d4-45f4-b06b-d01e53711241_fpkm,e85942cf-02d4-45f4-b06b-d01e53711241_count
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	OR
gdc__tissue_source_site__name	University of Michigan
gdc__tissue_source_site__tissue_source_site_id	2ff9cebf-b83f-5ec2-aae4-3aa1bf1bb02d
gdc__treatments__treatment_id	defa0bb1-65af-5a98-abd7-f88dcbe6020e
gdc__treatments__treatment_or_therapy	yes
gdc__treatments__treatment_type	Pharmaceutical Therapy, NOS,Pharmaceutical Therapy, NOS
gdc__type	gene_expression
gdc__updated_datetime	2019-09-18T14:38:42.659845+00:00
manually_curated__data_format	BED
manually_curated__download_date	2019-11-05T21:18:15.778+01:00
manually_curated__exp_data_bed_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/1fe73f5c-591d-4c55-ae0e-a67afb64f872-geq.bed
manually_curated__exp_metadata_url	ftp://geco.deib.polimi.it/opengdc/bed/tcga/tcga-acc/gene_expression_quantification/1fe73f5c-591d-4c55-ae0e-a67afb64f872-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5111422
manually_curated__local_md5	167742c8a340c46083225f0c977aa8c2
manually_curated__opengdc_download_date	2019-09-12T10:50:49.000000+02:00
manually_curated__opengdc_file_md5	1493c86e1547156c87574ada19a4f32e
manually_curated__opengdc_file_size	5111421
manually_curated__opengdc_id	1fe73f5c-591d-4c55-ae0e-a67afb64f872-geq
manually_curated__origin_file_size	5111421
manually_curated__origin_last_modified_date	Mon Sep 30 16:54:00 CEST 2019
manually_curated__origin_md5	1493c86e1547156c87574ada19a4f32e
manually_curated__tissue_status	tumoral
